Latest / Deep Tech Germany – AI, Robotics & Frontier Innovation by Startuprad.io™
Actitrex: Immune-Cell Therapy for Stem-Cell Transplants
Prof. Andrea Tüttenberg, co-founder of Actitrex, on immune-cell therapy to reduce severe immune responses in stem-cell transplantation.
Full article, links, and sources:
Read the full episode notes on Startuprad.io
Why this matters for deep tech: Immune-cell therapy is frontier biotech deep tech — long, capital-heavy science with the potential to change transplant outcomes.
In this episode, we cover:
Prof. Andrea Tüttenberg (Co-Founder, Actitrex)
Immune-cell therapy for stem-cell transplants
From doctor and researcher to founder
Funding and talent needs in biotech
Balancing clinical and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.